Here is an article about a study, published in the newsletter if the American Society of Clinical Oncologists , that states.... “.In a long-term follow-up of a phase III trial reported in the Journal of Clinical Oncology, Hoffman et al found that dose-escalated moderately hypofractionated intensity-modulated radiation therapy (HIMRT) improved disease control and reduced treatment duration vs conventionally fractionated IMRT (CIMRT) in localized prostate cancer
https://www.ascopost.com/news/59216
You will probably find articles that state the opposite, but that’s the nature of prostate cancer, we often find that we need to make our own decisions, after much research and with guidance from our Drs.
I am not going to offer much more advice as there are others here who will show up soon that have first hand experience with this type of diagnosis and are thus more knowledgeable than I.
Your husband is lucky to have you by his side, looking for info.
Suggestion, go to your profile page and create a signature with your husband’s virals, details on biopsy, his age, etc. it will help others respond to you in the future without having to dig back in the past to find your stats.
Good luck, and stick around for more detailed responses.
I am not a doctor, just another guy without a prostate
Dx Age 64 Nov 2014, PSA 4.3
BX 3 of 12 cores positive original pathology G6
RALP with Dr Ash Tewari Jan 6, 2015
Post surgical pathology G7 (3+4), - ECE, - Margins, -LN, -SV (+ frozen section apex converted to negative)
PSA @ 6 weeks 2/15, .<02, remained <0.02 until January 2017, .02, repeat Feb 2017, still .02. May 2017-.033, August 2017- .033 November .046, March 2018 .060. June 2018 .068, July 2018 - .082, August 2018, .078, August 2018 - .08 Start ADT. Sept 2018 Start SRT
Sept 2018 thru November 2018 – T = 4, PSA = <.05
Decipher test, low risk, .37 score
My story.... tinyurl.com/qgyu3xq
jmg153 said...
My husband, (age 64) was just diagnosed with Prostate Cancer. His biopsy results came back with a T2 aggressive, Gleason 9, PSA 74. The doctors said he needs to start hormone therapy asap and after two months he can either choose to have 45 regular radiation treatments, or 26 hypo fractionated treatments. There are two lymph nodes close to the prostate that they also want to radiate. We went to see two doctors and one said he wants to use the regular radiation treatment and the other wants to use hypo fractioned treatments. We don't know which one to choose. Both have their downfalls. We can't find enough research on the web about the differences in risk factors between them. Any help you can give us would be greatly appreciated.
thankfully they didn't recommend surgery! you've come to the right place to learn the differences in treatment. good luck to you both.
age - 64
12/09 - PSA 6.8
G7 - 3+4 - all 12 cores pos
HT, BT, IGRT
6/18 - 8-year post treatment PSA .1!
PSAs .2, .3, .2, .3, .2, .1, .2, .2, .1, .1, .1, .1, .1
"..You get braver as your options dwindle.." -- Fairwind
https://instagram.com/edraderphotography/
It's fine to do your homework but, in the end, you want to avoid the terrible fate of the indecisive mule who starved to death half way between two piles of hay.
65 Slow PSA rise 2007-2012: 1.4=>8
4 bxs 2010-2012: 1&2 neg, 3 pos 1/14 6(3+3) 3-4% (2nd opn. 7(3+4)), 4 neg
DaVinci 6/14/12. "some" nerve sparing on left
Path: pT3a pN0 R1 GS9(4+5) Pos margins on rt
24 mo ADT3 7/12 - 7/14
Adj IMRT 66.6 Gy 10/17/12-12/13/12
8/2012-3/2015: Incont., Trimix, VED, PSA<0.015.
AUS & IPP installed 3/5/2015
Forum Moderator - Not a medical professional
age - 64
12/09 - PSA 6.8
G7 - 3+4 - all 12 cores pos
HT, BT, IGRT
6/18 - 8-year post treatment PSA .1!
PSAs .2, .3, .2, .3, .2, .1, .2, .2, .1, .1, .1, .1, .1
"..You get braver as your options dwindle.." -- Fairwind
https://instagram.com/edraderphotography/
I presume your husband also had scans following his diagnosis--what were those results?
Age 58, Diagnosed at 51
PSA 9.6, Gleason: 9 (5+4), three 7s (3+4)
Chose triple play of HDR brachy, IMRT and HT (Casodex, Lupron and Zytiga)
Completed HT (18 months) in April 2014
3/19: PSA = 0.04
I assume the T2 classification came from MRI scans? Was the biopsy MRI guided? There will be a lot of questions so try to get the pertinent data in your signature or added to this thread.
No idea on which radiation is best for this but the G9 high risk situation may limit options based on some limited studies I have seen. Sounds like you need a tiebreaker so you should consider an opinion from possibly a well known cancer center where multiple doctor types can take a look at your husband’s situation and all treatments are available so they can agree, disagree, or offer other options.
Good luck
7/2018-66yo,PSA 4.1->5.1
8/2018-MRI, PI-RADS 5
8/2018-MRI Biopsy, 4+3
9/2018-CT/Bone clear
11/6/18-RALP @ St. Johns
11/2018-Post-Op Path G7 (4+3) 5% Tert Gr 5, pT3a pN0 Grade 3
Pos. Marg (SM+), EPE, <3mm, L=0.1mm?
11/2018-Decipher 0.47, Ave. Risk, 4.3%/4.8%
1/2019-Epstein-G9(4+5) Gr5
“Difficult to distinguish EPE vs intraprostatic incision, 3mm” Extent:pT2x
2/2019-PSA<0.10
4/2019-Begin ART
Both are good options. The hypo fraction (26 treatments) might have fewer side effects from RT. I had the hypo fraction with a DX of G7. I think you'll have trouble finding clear evidence to differentiate the two.
And honestly - it's the HT that's going to be the most effective here. I'd go with the doctor you feel you work better with and feel you have more trust in.
Andrew
I'll be in the shop.
Age 59, 52 at DX
PSA:
4.2 10/11, 1.9 6/12, 1.2 12/12, 1.0 5/13, .6 11/13,
.7 5/14, .5 10/14, .5 4/15, .3 10/15, .3 4/16, .4 10/16, .4 5/17, .3 10/17 .3 4/18, .4 11/18
G 3+4
Stage T1C
2 out of 14 cores positive
Treatment IGRT - 2/2012
Age now 75 . Diagnosed G-9 6/2010. RALP, Radiation failed
Lupron, Zytiga, PSA <0.1 10/16 no change <0.1 5/17 PSA 1.6 Chemo or Provenge next..Sept '17, PSA now 9.2. ADT including Zytiga has failed. Will investigate treatment options. 11/17 PET/CT clear, but 4 new bone mets..Going to try Xtandi...3/2018 PSA now 54, chemo next. 5/10/18, PSA 200, Dosetaxel started..5/19 PSA300. R-223 ?
https://www.ncbi.nlm.nih.gov/pubmed/30106637
This is the 'official' (peer-reviewed) paper that Pratoman referred to earlier in this thread.
Here is a link to an earlier thread with valuable info on the topic at hand:
https://www.healingwell.com/community/default.aspx?f=35&m=3809812
Post Edited (Sr Sailor) : 5/26/2019 8:34:05 PM (GMT-6)
Where are you located?
PSA 59 on 8-26-2010 age 60. Biopsy 9-8-2010 12/12 positive, 20-80% involved, PNI in 3 cores, G 3+3,3+4,and 4+3=G7, T2b.
Eligard and Jalyn started on 10-7-2010. IMRT to prostate and lymph nodes started on 11-8-2010, HDR Brachytherapy December 6 and 13, 2010.
PSA < .1 since February 2011. Located in Cumming Georgia north of Atlanta
Age now 75 . Diagnosed G-9 6/2010. RALP, Radiation failed
Lupron, Zytiga, PSA <0.1 10/16 no change <0.1 5/17 PSA 1.6 Chemo or Provenge next..Sept '17, PSA now 9.2. ADT including Zytiga has failed. Will investigate treatment options. 11/17 PET/CT clear, but 4 new bone mets..Going to try Xtandi...3/2018 PSA now 54, chemo next. 5/10/18, PSA 200, Dosetaxel started..5/19 PSA300. R-223 ?
jmg153 said...
My husband, (age 64) was just diagnosed with Prostate Cancer. His biopsy results came back with a T2 aggressive, Gleason 9, PSA 74. The doctors said he needs to start hormone therapy asap and after two months he can either choose to have 45 regular radiation treatments, or 26 hypo fractionated treatments. There are two lymph nodes close to the prostate that they also want to irradiate.
Considering the seriousness of this case, I also recommend that you both look into a 'triple play'. In other words, a combination of hormone therapy and two modes of radiation. My own case (see below) wasn't as advanced as your husband's, but that is what I ultimately decided on. I had SBRT (Stereotactic Body Radiation Therapy) as one of the modalities (in a clinical trial), but brachytherapy is more conventional. But one needs to find a RO or group that has serious experience in those areas.
DOB 1940
Dec 2012: GP felt a nodule and hardened prostate; confirmed by urologist
PSA: 11.9 ng/ml
Biopsy (3/1/2013): Several Gleason 4+5 loci (prostate=45 ml)
Stage: T2c
Transferred to RO
Casodex 1 month; then Lupron 5/13 through 12/14 (18 months total)
Jul-Sep 2013: SBRT (CyberKnife; 3 x 6.5 Gy) followed by IMRT (25 x 1.8 Gy)
Lowest PSA thereafter: 0.1 (3/20/15)
Latest (09/18) PSA = 1.4 ng/ml
My original dx was PSA 12.4 and a GS9. As several of the folks have advised above, I would look for a triple play. With a highly aggressive GS9, you want to throw everything at it that you can. I had ADT for 18 months to lower and control the Pca, and during that time low dose brachytherapy followed by SBRT. The SBRT was done in 5 fractions over 5 days. The SBRT is very effective and save the patient from a lot of stress and worry. Its over and done with quickly. The 18 month ADT was the hardest to deal with. Almost a year after ending ADT treatment, I still get some side effects, but they are manageable.
You haven’t mentioned what geographic area you are in. I’m sure others can chime in with exceptional treatment facilities in your area. Find a facility and a doctor you are comfortable with. Ask questions of them, take notes, and be your own advocate. You need to be the one in control of your situation. Feel free to ask any questions you have here also and remember that we have all been where you (your husband) is right now. Physically and mentally. Keep us informed
Age at Dx. 63. PSA 12/16 12.4
GS 9 (4+5)
1/17 CT Scan & bone scan, negative
2/2/17 prostate MRI.
2/27/17 pelvic bone biopsy done. No mets
3/7/17 Triple play w/HT. Degarelix, 4/17 lupron (1-2 years)
7/7/17 LDR Brachy (Zelefsky MSK)
8/25/17 SHARP (SBRT) MSK
9/23/18 off the lupron train (18 months)
PSA 1/08 1.4, 12/16 12.4, 4/17 3.8 (HT), 7/17 1.05 (HT), 10/17 <.05 (HT), 1/18 <0.05 (HT), 4/18 <.05 (HT) T=7, 7/18 <.05 (HT) T=6, (off lupron), 10/18 <.05 T=6, 2/19 <.05 T=57
Post Edited (Dogdays) : 5/29/2019 7:50:34 AM (GMT-6)
He was diagnosed at 48 years young with prostate cancer, Gleason score 9 post radical prostecemy, with residual PSA 2 or less post surgery (26+ PSA pre-surgery). Dr. T (radiation onc) at CCF recommended EBRT and lupron. The lupron (androgen deprivation therapy) worked against my husband (and does so in 20% of cases per this study) - and exacerbated the cancer to a highly aggressive (poorly differentiated) neuroendocrine carcinoma in his liver and spine.
https://journals.lww.com/oncology-times/pages/articleviewer.aspx?year=2015&issue=02250&article=00003&type=Fulltext
NewHere123 said...
Please look at this article before you decide on hormone therapy. Really trying to be informative rather than upsetting. Earlier this year, my husband died at the age of 50 years old after only 1.5 year battle with prostate cancer that morphed into poorly differentiated neuroendocrine carcinoma.
He was diagnosed at 48 years young with prostate cancer, Gleason score 9 post radical prostecemy, with residual PSA 2 or less post surgery (26+ PSA pre-surgery). Dr. T (radiation onc) at CCF recommended EBRT and lupron. The lupron (androgen deprivation therapy) worked against my husband (and does so in 20% of cases per this study) - and exacerbated the cancer to a highly aggressive (poorly differentiated) neuroendocrine carcinoma in his liver and spine.
https://journals.lww.com/oncology-times/pages/articleviewer.aspx?year=2015&issue=02250&article=00003&type=fulltext
No comment. Just wanted to make the url clickable.
But, a few comments about the numbers:
The paper said...
"Neuroendocrine prostate cancer is a high-risk, lethal subset of disease, often referred to as representing only two percent of all diagnosed prostate cancer. In fact, though, it [bold]probably occurs far more often[/bold] because the disease is not recognized as different from metastatic castration-resistant prostate cancer. That was the word from Himisha Beltran, MD, Assistant Professor of Medicine in the Division of Medical Oncology at Weill Cornell Medical College, speaking here at the Chemotherapy Foundation Symposium."
"Men rarely undergo biopsy of their tumors once those tumors have spread to bone or soft tissue regions of the body, Beltran noted. So while only a few prostate cancers are diagnosed originally as neuroendocrine prostate cancer, many cases that develop after adenocarcinoma has evolved into neuroendocrine prostate cancer go undetected. She estimated that as many as one quarter of patients who are dying of prostate cancer are dying from treatment-related neuroendocrine prostate cancer."
Note that the two percentages -- 2% and nearly one quarter ~20% -- are based on different populations -- 2% of all men diagnosed vs 20% of men dying of prostate cancer. A small percentage of men diagnosed go on to die of the disease so that 20% of men who subsequently die represents a small percentage of all men diagnosed. Actually, I wouldn't be surprised if the two percent figure turned out to be bigger.
The takeaway here is that if you are known to have neuroendocrine prostate cancer you should probably stay away from hormone therapy. But neuroendocrine prostate cancer is rare and hard to identify. Most cases are identified, if at all, by the progression of the disease in its later stages. If all you know is that you have prostate cancer then you should remember that the 2% of men who will respond poorly is baked into the statistics for the various treatment options. For a mix of men diagnosed with high-risk prostate cancer, a few percent of whom may respond poorly to treatment, radiation will cure some percentage and radiation plus ADT will cure some larger percentage. Unless they find an effective way to screen for neuroendocrine disease earlier in the process you have to go with the overall stats for all high-risk men in making treatment decisions, and overall ADT seems to improve the results with some forms of radiation treatments.
65 Slow PSA rise 2007-2012: 1.4=>8
4 bxs 2010-2012: 1&2 neg, 3 pos 1/14 6(3+3) 3-4% (2nd opn. 7(3+4)), 4 neg
DaVinci 6/14/12. "some" nerve sparing on left
Path: pT3a pN0 R1 GS9(4+5) Pos margins on rt
24 mo ADT3 7/12 - 7/14
Adj IMRT 66.6 Gy 10/17/12-12/13/12
8/2012-3/2015: Incont., Trimix, VED, PSA<0.015.
AUS & IPP installed 3/5/2015
Forum Moderator - Not a medical professional
Post Edited (PeterDisAbelard.) : 5/31/2019 8:54:14 AM (GMT-6)